Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ascendis Pharma A (ASND) Return on Capital Employed (2016 - 2025)

Historic Return on Capital Employed for Ascendis Pharma A (ASND) over the last 11 years, with Q4 2025 value amounting to 0.77%.

  • Ascendis Pharma A's Return on Capital Employed rose 3900.0% to 0.77% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.77%, marking a year-over-year increase of 3900.0%. This contributed to the annual value of 0.98% for FY2025, which is 18800.0% up from last year.
  • Ascendis Pharma A's Return on Capital Employed amounted to 0.77% in Q4 2025, which was up 3900.0% from 1.14% recorded in Q3 2025.
  • In the past 5 years, Ascendis Pharma A's Return on Capital Employed registered a high of 5.57% during Q2 2024, and its lowest value of 32.5% during Q1 2024.
  • For the 5-year period, Ascendis Pharma A's Return on Capital Employed averaged around 2.36%, with its median value being 0.73% (2023).
  • As far as peak fluctuations go, Ascendis Pharma A's Return on Capital Employed crashed by -318100bps in 2024, and later surged by 311100bps in 2025.
  • Over the past 5 years, Ascendis Pharma A's Return on Capital Employed (Quarter) stood at 0.31% in 2021, then crashed by -89bps to 0.58% in 2022, then crashed by -572bps to 3.88% in 2023, then surged by 70bps to 1.16% in 2024, then skyrocketed by 34bps to 0.77% in 2025.
  • Its Return on Capital Employed was 0.77% in Q4 2025, compared to 1.14% in Q3 2025 and 2.38% in Q2 2025.